UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Correction to: Hormonal modulation of ESR1 mutant metastasis

Oncogene, 2022-01, Vol.41 (3), p.460-460

2022

Volltextzugriff (PDF)

Abstract 3146: Circulating tumor DNA assay performance for detection and monitoring of KRAS mutations in urine from patients with advanced cancers

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3146-3146

2016

Volltextzugriff (PDF)

Abstract 493: Quantity of KRAS mutations in cell-free DNA is associated with survival of patients with advanced cancers

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.493-493

2016

Volltextzugriff (PDF)

Effort, reward, and vigor in decision-making and motor control

Current biology, 2016-06, Vol.26 (14), p.1929-1934

2016

Volltextzugriff (PDF)

Abstract 573: BRAF, KRAS, and NRAS mutations in archival tumor samples and samples of cell-free DNA from serum and bone marrow aspirates from patients with multiple myeloma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.573-573

2018

Volltextzugriff (PDF)

Step-to-step variability indicates disruption to balance control when linking the arms and legs during treadmill walking

PloS one, 2022-01, Vol.17 (3), p.e0265750

2022

Volltextzugriff (PDF)

Abstract 1979: Enhancing cell-free DNA and mutant copy recovery from plasma with novel liquid-liquid extraction

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1979-1979

2020

Volltextzugriff (PDF)

Abstract 734: Monitoring of dynamic changes and clonal evolution in circulating tumor DNA from patients with IDH-mutated cholangiocarcinoma treated with IDH inhibitors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.734-734

2020

Volltextzugriff (PDF)

Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of cancer therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3533-3533

2020

Volltextzugriff (PDF)

Abstract PO058: Targeted next-generation sequencing (NGS) of 105 cancer-related genes in circulating tumor DNA (ctDNA) from patients with advanced cancers treated with immune checkpoint inhibitors (iCPI)

Cancer immunology research, 2021-02, Vol.9 (2_Supplement), p.PO058-PO058

2021

Volltextzugriff (PDF)

CT-based radiogenomic signature to identify isocitrate dehydrogenase (IDH)1/2 mutations in advanced intrahepatic cholangiocarcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4081-4081

2019

Volltextzugriff (PDF)

Abstract P1-19-18: Everolimus, letrozole and trastuzumab in hormone receptor-positive, HER2-positive/amplified or mutant metastatic cancer: Evaluating synergy and overcoming resistance

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-18

2020

Volltextzugriff (PDF)

Abstract PR10: PIK3CA mutations in plasma cell-free DNA predict survival and treatment outcomes in patients with advanced cancers

Molecular cancer research, 2020-10, Vol.18 (10_Supplement), p.PR10-PR10

2020

Volltextzugriff (PDF)

Ultrasensitive Detection of BRAF Mutations in Circulating Tumor DNA of Patients With Metastatic Thyroid Cancer

Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A872-A873

2021

Volltextzugriff (PDF)

Abstract 5381: A highly sensitive method for noninvasive cancer profiling through targeted methylation sequencing of circulating cell-free DNA

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5381-5381

2017

Volltextzugriff (PDF)

Abstract 5687: Detection and monitoring of IDH mutations in unamplified plasma cell-free DNA in patients with advanced cancers treated with IDH inhibitors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5687-5687

2017

Volltextzugriff (PDF)

Abstract 5152: Mutation-agnostic detection of colorectal cancer-specific cell-free DNA using targeted methylation sequencing

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5152-5152

2022

Volltextzugriff (PDF)

Abstract 642: Detection of circulating antibodies against KRAS in patients with advanced cancers

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.642-642

2017

Volltextzugriff (PDF)

Liquid biopsies of plasma exosomal nucleic acids, plasma cell-free DNA, and survival of patients with advanced cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11551-11551

2017

Volltextzugriff (PDF)

Mutation enrichment next-generation sequencing for quantitative detection of KRAS mutations in urine cell-free DNA from patients with advanced colorectal and other cancers

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.602-602

2017

Volltextzugriff (PDF)

MEKK3 EXPRESSION CORRELATES WITH NFκB ACTIVITY AND WITH EXPRESSION OF ANTI-APOPTOTIC GENES IN SEROUS OVARIAN CARCINOMA

Cancer, 2009-09, Vol.115 (17), p.3897-3908

2009

Volltextzugriff (PDF)

Abstract 2414: Novel, ultra deep next-generation sequencing of plasma cell-free DNA from patients with advanced cancers

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2414-2414

2015

Volltextzugriff (PDF)

Upper and Lower Limb Muscle Activation Is Bidirectionally and lpsilaterally Coupled

Medicine and science in sports and exercise, 2009, Vol.41 (9), p.1778-1789

2009

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Aktive Filter

ThemaMice

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Author
(21)
Humans
(20)
Female
(11)
Male
(11)
Adult
(9)
Biological And Medical Sciences
(8)
Fundamental And Applied Biological Sciences. Psychology
(6)
Middle Aged
(6)
Aged
(5)
Neurology
(5)
Diagnosis
(4)
Health Aspects
(4)
Medical Sciences
(4)
Treatment Outcome
(4)
Young Adult
(4)
Adolescent
(3)
Diseases
(3)
Evidence-Based Medicine
(3)
Genomes
(3)
Histology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Correction to: Hormonal modulation of ESR1 mutant metastasis

Abstract 3146: Circulating tumor DNA assay performance for detection and monitoring of KRAS mutations in urine from patients with advanced cancers

Abstract 493: Quantity of KRAS mutations in cell-free DNA is associated with survival of patients with advanced cancers

Effort, reward, and vigor in decision-making and motor control

Abstract 573: BRAF, KRAS, and NRAS mutations in archival tumor samples and samples of cell-free DNA from serum and bone marrow aspirates from patients with multiple myeloma

Step-to-step variability indicates disruption to balance control when linking the arms and legs during treadmill walking

Abstract 1979: Enhancing cell-free DNA and mutant copy recovery from plasma with novel liquid-liquid extraction

Abstract 734: Monitoring of dynamic changes and clonal evolution in circulating tumor DNA from patients with IDH-mutated cholangiocarcinoma treated with IDH inhibitors

Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of cancer therapy

Abstract PO058: Targeted next-generation sequencing (NGS) of 105 cancer-related genes in circulating tumor DNA (ctDNA) from patients with advanced cancers treated with immune checkpoint inhibitors (iCPI)

CT-based radiogenomic signature to identify isocitrate dehydrogenase (IDH)1/2 mutations in advanced intrahepatic cholangiocarcinoma

Abstract P1-19-18: Everolimus, letrozole and trastuzumab in hormone receptor-positive, HER2-positive/amplified or mutant metastatic cancer: Evaluating synergy and overcoming resistance

Abstract PR10: PIK3CA mutations in plasma cell-free DNA predict survival and treatment outcomes in patients with advanced cancers

Ultrasensitive Detection of BRAF Mutations in Circulating Tumor DNA of Patients With Metastatic Thyroid Cancer

Phase I Study of the Combination of Vemurafenib, Carboplatin, and Paclitaxel in Patients with BRAF-Mutated Melanoma and Other Advanced Malignancies

Abstract 5381: A highly sensitive method for noninvasive cancer profiling through targeted methylation sequencing of circulating cell-free DNA

Abstract 5687: Detection and monitoring of IDH mutations in unamplified plasma cell-free DNA in patients with advanced cancers treated with IDH inhibitors

Abstract 5152: Mutation-agnostic detection of colorectal cancer-specific cell-free DNA using targeted methylation sequencing

Abstract 642: Detection of circulating antibodies against KRAS in patients with advanced cancers

Liquid biopsies of plasma exosomal nucleic acids, plasma cell-free DNA, and survival of patients with advanced cancers

Mutation enrichment next-generation sequencing for quantitative detection of KRAS mutations in urine cell-free DNA from patients with advanced colorectal and other cancers

MEKK3 EXPRESSION CORRELATES WITH NFκB ACTIVITY AND WITH EXPRESSION OF ANTI-APOPTOTIC GENES IN SEROUS OVARIAN CARCINOMA

Development and validation of an ultra-deep next-generation sequencing assay for testing of plasma cell-free DNA from patients with advanced cancer

Abstract 2414: Novel, ultra deep next-generation sequencing of plasma cell-free DNA from patients with advanced cancers

Upper and Lower Limb Muscle Activation Is Bidirectionally and lpsilaterally Coupled

Aktive Filter

Suchergebnisse filtern